Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA 2023 Annual Report Download
…The active involvement of our community through the Patients as Partners in Research platform is crucial—research cannot advance without the community at its core. SPONSORED RESEARCH PROJECTS In 2023, nine…
2023 CMTA Annual Report
…The active involvement of our community through the Patients as Partners in Research platform is crucial—research cannot advance without the community at its core. SPONSORED RESEARCH PROJECTS In 2023, nine…
CMTA 2023 Annual Report Download
…Research Funding since 1983 CMTA Centers of Excellence Patients as Partners in Research 30+ Active Research Projects 40+ Research Partners 83 CMTA Branch Meetings $383,722 Raised by WALK & CYCLE…
Gene Replacement Therapy in CMT4 Subtypes
…of accelerating gene replacement therapies for CMT, underscoring our leadership in this critical area of research,” said Katherine Forsey, PhD, CMTA Chief Research Officer. “This investment in gene replacement therapy…
CMTA Report_Winter 2024 – STAR Special Edition_Download
…REPORT 1 A LETTER FROM SUE, OUR CEO Chief Research Officer, Katherine Forsey, PhD at CMTA’s 2024 Patient and Research Summit in Denver, CO FROM PATIENTS TO RESEARCH: CMTA’S iPSC…
2023 CMTA Annual Report
…$24 Million+ in Research Funding since 1983 CMTA Centers of Excellence Patients as Partners in Research 30+ Active Research Projects 40+ Research Partners 83 CMTA Branch Meetings $383,722 Raised by…
CMTA 2023 Annual Report
…Research ToolsStem Cell Lines – BiobankNew York STEM Cell Foundation Preclinical – CompletedSmall MoleculeResearch Foundation for the State University of New York Preclinical – CompletedSmall MoleculeResearch Foundation for the State…
Three Major Patient Advocacy Groups Focused on CMT Research Collaborating on FDA “Voice of the Patient” Report
…condition. We thank the HNF for coordinating this important meeting and the MDA for their partnership. We believe this collaboration will help accelerate research and treatments for CMT patients worldwide….
CMT1A Research Breakthrough!
…hopeful breakthrough for medical researchers, healthcare professionals, patients, and families. Ionis researchers used their expertise as a world leader in developing antisense oligonucleotides, which precisely target the products of genes…
Development of Advanced Research Diagnostic Capabilities for the CMT Community
…to address this issue by aggregating genetic data (panels, exomes, and genomes) from patients into a common database. This database is available to qualified researchers in the field and this…